Article content
Advocates across the country are calling on provincial governments to adjust COVID-19 vaccine prioritization so cancer patients receive their second dose within four weeks rather than waiting up to 16 weeks.
Concern over a delayed second dose comes from preliminary data out of the U.K. which found people with solid cancers (a physical tumour) and blood cancers had a much lower antibody response following just one dose of the Pfizer vaccine compared to healthy people. When a second booster was given 21 days later, nearly all solid cancer patients had a much higher antibody response. This means delaying a second dose could prevent patients from having a fuller response to the vaccine and leaves them susceptible to COVID-19 while they wait for their second jab.
Are COVID-19 vaccines safe for cancer patients?
Despite the limited data, medical groups, doctors, and cancer experts are pushing for vaccination of most cancer patients
February 8, 2021 10:39 GMT
With an increasing number of individuals who are getting their COVID-19 vaccines, cancer patients are in a quandary on whether they should be vaccinated. Now, a number of cancer experts have weighed in on the issue.
The American Cancer Society (ACS) has revealed that there is a general consensus that vaccines are considered safe for most cancer patients. However, the health society admitted that there is still not much data on whether the vaccine will be effective for patients with cancer. What the body suggests is for cancer patients to discuss their options with their doctor.
Are Covid-19 vaccines safe for cancer patients? Here is what cancer experts say kvia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kvia.com Daily Mail and Mail on Sunday newspapers.